Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study

Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study

We aim to identify risk factors of major adverse cardio-cerebrovascular events (MACCE) using a proxy of drug treatment for a MACCE after the start of statin therapy in the primary cardiovascular prevention group, taking drug dose, persistency and adherence into account. We conducted a retrospective...

Full description

Bibliographic Details
Main Authors: Dennis Steenhuis, Stijn de Vos, Jens H.J. Bos, Eelko Hak
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Preventive Medicine Reports
Subjects:
Statin therapy
HMG-CoA reductase inhibitors
Primary prevention
Cardio-cerebrovascular events
Pharmacoepidemiology
Risk factors
Online Access:http://www.sciencedirect.com/science/article/pii/S2211335523001493

Internet

http://www.sciencedirect.com/science/article/pii/S2211335523001493

Similar Items